SCHEMBL24909113

SCHEMBL24909113

CC(C)(C)OC(=O)N1CC=C[C@@H]1CO[Si](C)(C)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.35
TSHR P16473 4/20 0.33
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PREP P48147 1/20 0.33
LMNA P02545 3/20 0.32
NPSR1 Q6W5P4 2/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
HTT P42858 1/20 0.32
CTSK P43235 1/20 0.32
USP2 O75604 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
ATM Q13315 2/20 0.32
CYP1A2 P05177 1/20 0.32
POLB P06746 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17137099 1.00 ALDH1A1 (0.35) ALDH1A1TSHRMEN1KMT2AL3MBTL1
SCHEMBL17137102 1.00 ALDH1A1 (0.35) ALDH1A1TSHRMEN1KMT2AL3MBTL1
SCHEMBL22950784 0.88 ATM (0.32) ALDH1A1MEN1KMT2AL3MBTL1PREP
SCHEMBL22950853 0.85 PREP (0.35) ALDH1A1MEN1KMT2APREPLMNA
SCHEMBL24909669 0.82 ALDH1A1 (0.34) ALDH1A1TSHRMEN1KMT2AL3MBTL1
SCHEMBL15320255 0.82 ABHD6 (0.34) ALDH1A1TSHRMEN1KMT2AL3MBTL1
SCHEMBL15320256 0.82 ABHD6 (0.34) ALDH1A1TSHRMEN1KMT2AL3MBTL1
SCHEMBL31567206 0.81 PREP (0.34) ALDH1A1MEN1KMT2APREPLMNA
SCHEMBL15320368 0.81 ALDH1A1 (0.38) ALDH1A1TSHRMEN1KMT2AL3MBTL1
SCHEMBL15320366 0.81 ALDH1A1 (0.38) ALDH1A1TSHRMEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230012570-A1 BICYCLIC COMPOUND USED AS SELECTIVE ANDROGEN RECEPTOR MODULATOR MEDSHINE DISCOVERY INC. (CN) 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230012570-A1 BICYCLIC COMPOUND USED AS SELECTIVE ANDROGEN RECEPTOR MODULATOR AR, NR5A1, CYP17A1 ALDH1A1 936/4885TSHR 1121/4885MEN1 3477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.